[Chronic myelogenous leukaemia as a possible consequence of immunosuppressive treatment of nephrotic syndrome (author's transl)]

Monatsschr Kinderheilkd (1902). 1975 Oct;123(10):718-20.
[Article in German]

Abstract

A boy, aged 14, suffered since his 5th year from nephrotic syndrome. During the first 7 years he had been treated with adrenocorticosteroids, but his condition hardly improved. Then a cyclophosphamide treatment was started with a total dosis of 5 g in 50 days. The nephrotic syndrome had disappeared, but relapsed 3 years afterwards, this time accompanied by chronic myelogenous leukaemia. The possibility of the onset of chronic myelogenous leukaemia in connection with the immunosuppressive therapy (adrenocorticosteroids and cyclophosphamide) is discussed.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adolescent
  • Adrenal Cortex Hormones / adverse effects
  • Adrenal Cortex Hormones / therapeutic use
  • Cyclophosphamide / adverse effects
  • Cyclophosphamide / therapeutic use
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Leukemia, Myeloid / chemically induced*
  • Male
  • Nephrotic Syndrome / drug therapy*
  • Time Factors

Substances

  • Adrenal Cortex Hormones
  • Immunosuppressive Agents
  • Cyclophosphamide